Pfizer Promoting Tiered Drug Coverage Policy For Middle-Income Nations
Executive Summary
Pfizer is advocating a new U.S. trade stance toward setting parameters around foreign governments' drug reimbursement policies in middle-income nations
You may also be interested in...
Intellectual Property Bill Would Sanction Countries That Fail U.S. Rules
A Senate bill would block bank loans to countries that fail to implement intellectual property protections mandated by the U.S. government
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.
Biden vs Trump On Drug Pricing And Unfinished Business
While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former President Trump could look to put his stamp on drug pricing reform by resurrecting one of his former policies involving international reference pricing and Medicare Part B drugs.